NO148491C - Analogifremgangsmaate ved fremstilling av antiinflammatorisk virksomme 21-salisylsyre- og 21-acetylsalicylsyreestre av steroider av pregnanserien - Google Patents

Analogifremgangsmaate ved fremstilling av antiinflammatorisk virksomme 21-salisylsyre- og 21-acetylsalicylsyreestre av steroider av pregnanserien

Info

Publication number
NO148491C
NO148491C NO774525A NO774525A NO148491C NO 148491 C NO148491 C NO 148491C NO 774525 A NO774525 A NO 774525A NO 774525 A NO774525 A NO 774525A NO 148491 C NO148491 C NO 148491C
Authority
NO
Norway
Prior art keywords
inflammatorally
pregnancy
steroids
preparation
effective
Prior art date
Application number
NO774525A
Other languages
English (en)
Norwegian (no)
Other versions
NO148491B (no
NO774525L (no
Inventor
Albert Meli
Gaetano Palladino
Marco Da Col
Pier Paolo Castelli
Original Assignee
Lark Spa
Menarini Sas
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lark Spa, Menarini Sas filed Critical Lark Spa
Publication of NO774525L publication Critical patent/NO774525L/no
Publication of NO148491B publication Critical patent/NO148491B/no
Publication of NO148491C publication Critical patent/NO148491C/no

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J31/00Normal steroids containing one or more sulfur atoms not belonging to a hetero ring
    • C07J31/006Normal steroids containing one or more sulfur atoms not belonging to a hetero ring not covered by C07J31/003
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J5/00Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond
    • C07J5/0046Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond substituted in position 17 alfa
    • C07J5/0053Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond substituted in position 17 alfa not substituted in position 16
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J5/00Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond
    • C07J5/0046Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond substituted in position 17 alfa
    • C07J5/0061Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond substituted in position 17 alfa substituted in position 16
    • C07J5/0069Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond substituted in position 17 alfa substituted in position 16 by a saturated or unsaturated hydrocarbon group
    • C07J5/0076Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond substituted in position 17 alfa substituted in position 16 by a saturated or unsaturated hydrocarbon group by an alkyl group

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Rheumatology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pain & Pain Management (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Steroid Compounds (AREA)
NO774525A 1976-12-31 1977-12-30 Analogifremgangsmaate ved fremstilling av antiinflammatorisk virksomme 21-salisylsyre- og 21-acetylsalicylsyreestre av steroider av pregnanserien NO148491C (no)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB54510/76A GB1593978A (en) 1976-12-31 1976-12-31 Anti-inflammatory steroids

Publications (3)

Publication Number Publication Date
NO774525L NO774525L (no) 1978-07-03
NO148491B NO148491B (no) 1983-07-11
NO148491C true NO148491C (no) 1983-10-19

Family

ID=10471258

Family Applications (1)

Application Number Title Priority Date Filing Date
NO774525A NO148491C (no) 1976-12-31 1977-12-30 Analogifremgangsmaate ved fremstilling av antiinflammatorisk virksomme 21-salisylsyre- og 21-acetylsalicylsyreestre av steroider av pregnanserien

Country Status (10)

Country Link
JP (1) JPS53144561A (fi)
BE (1) BE862507A (fi)
CH (1) CH633301A5 (fi)
DK (1) DK155673C (fi)
FI (1) FI63422C (fi)
FR (1) FR2376160A1 (fi)
GB (1) GB1593978A (fi)
NL (1) NL7714482A (fi)
NO (1) NO148491C (fi)
SE (1) SE430607B (fi)

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1440063A (en) * 1972-08-11 1976-06-23 Glaxo Lab Ltd 17alpha-esters of 17alpha,21-dihydroxy-20-oxo-steroids

Also Published As

Publication number Publication date
SE7714976L (sv) 1978-07-02
FR2376160B1 (fi) 1980-11-14
JPS6220197B2 (fi) 1987-05-06
CH633301A5 (en) 1982-11-30
FI773929A (fi) 1978-07-01
BE862507A (fr) 1978-04-14
FI63422B (fi) 1983-02-28
DK155673B (da) 1989-05-01
NO148491B (no) 1983-07-11
JPS53144561A (en) 1978-12-15
FR2376160A1 (fr) 1978-07-28
NL7714482A (nl) 1978-07-04
DK581677A (da) 1978-07-01
SE430607B (sv) 1983-11-28
FI63422C (fi) 1983-06-10
GB1593978A (en) 1981-07-22
DK155673C (da) 1989-09-04
NO774525L (no) 1978-07-03

Similar Documents

Publication Publication Date Title
SE432420B (sv) Forfarande for framstellning av terapeutiskt verksamma hydroxamsyror
NO151622C (no) Analogifremgangsmaate ved fremstilling av terapeutisk aktive carboxyalkyldipeptider
MX5502E (es) Procedimiento para la preparacion de eteres y esteres de oximas
SE7801428L (sv) Forfarande for framstellning av cefemkarbonsyror
NO812197L (no) Fremgangsmaate ved fremstilling av 10-alkynylsteroider
NO771578L (no) Fremgangsmaate for fremstilling av di-n-propyleddiksyre
NO147953C (no) Analogifremgangsmaate ved fremstilling av terapeutisk aktive antracyklinglukosider
SE7714349L (sv) Forfarande for framstellning av hydroxamsyror
NO152255C (no) Analogifremgangsmaate for fremstilling av terapeutisk virksomme imidazolylvinylethere
NO148069C (no) Fremgangsmaate ved fremstilling av alfa-l-aspartyl-l-fenylalanin-methylester
NO780777L (no) Fremgangsmaate ved fremstilling av 1-azaxanthon-3-carboxylsyrer
SE7901000L (sv) Forfarande for framstellning av terpenoidestrar av steroider
NO792651L (no) Fremgangsmaate for fremstilling av spesielle steroider
NO152605C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive 2-pyridyl- og 2-pyrimidylaminobenzoesyrer
SE421787B (sv) Forfarande for framstellning av kvadratsyra
NO773622L (no) Fremgangsmaate til fremstilling av tereftalsyre
NO148491C (no) Analogifremgangsmaate ved fremstilling av antiinflammatorisk virksomme 21-salisylsyre- og 21-acetylsalicylsyreestre av steroider av pregnanserien
NO141716C (no) Fremgangsmaate for fremstilling av tiokarbaminsyreestere
NO143346C (no) Fremgangsmaate ved fremstilling av thymosin alfa1
NO772889L (no) Fremgangsmaate ved fremstilling av dietnaeringsmiddel
SE7702922L (sv) Forfarande for framstellning av (2-pyrimidinyl-tio)-alkansyraamider
SE7804856L (sv) Forfarande vid framstellning av sampolymerisat av maleinsyraanhydrid och vinyltrialkoxisilaner
NO147303C (no) Fremgangsmaate ved fremstilling og utvinning av halogenacetamider
SE430416B (sv) Forfarande for framstellning av alkoxisubstituerade tiofenkarboxylsyror och estrar derav
IL52868A0 (en) The preparation of esters of thiocarbamic acids